UCSD VENOUS INCIDENCE STUDY

加州大学圣地亚哥分校静脉发生率研究

• 批准号: 7950985
• 负责人: MICHAEL H CRIQUI
• 金额: $ 0.06万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950985
• 关键词: Accounting; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Disease; Disease Progression; Economics; Epidemiology; Funding; Grant; Incidence; Institution; Morbidity - disease rate; Prevalence; Quality of life; Research; Research Personnel; Resources; Risk Factors; Source; Symptoms; United States National Institutes of Health; Venous; Venous Insufficiency; Woman; cohort; indexing; men

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Specific Aims 1. To determine the eleven-year incidence of new venous disease, and progression of existing disease, in a multi-ethnic cohort of 1600 men and women who had their venous status(prevalence) accurately determined at baseline. 2. To evaluate risk factors for incident and progressive venous disease. 3. To determine the temporal relation of symptoms to venous disease; i.e. can symptoms precede(as well as follow) incident or progressive venous disease? 4. a) to evaluate change in a quality of life, accompanying incident or progressive venous disease accounting for changes in non-venous morbidity. b) to utlize a new comprehensive, validated QOL and symptom index, the Venous Insufficiency Epidemiological and Economic Study

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 具体目标 1. 在一个由 1600 名男性和女性组成的多种族队列中确定新静脉疾病的 11 年发病率以及现有疾病的进展，这些队列在基线时准确确定了他们的静脉状态（患病率）。 2. 评估发生和进展性静脉疾病的危险因素。 3. 确定症状与静脉疾病的时间关系；即，症状是否可以在事件或进行性静脉疾病之前（以及之后）出现？ 4. a) 评估生活质量的变化、伴随事件或进行性静脉疾病导致非静脉发病率的变化。 b) 利用新的全面、经过验证的生活质量和症状指数，即静脉功能不全流行病学和经济研究